Researchers discover gene variant linked to meningiomas

The causes of brain tumours have been hard to discern in most cases. But Umeå researchers have previously identified an inherited predisposition for brain tumours, and now, in an international collaboration, they have also discovered a genetic variation that increases the risk of a certain type of brain tumour, called meningiomas.

Approximately 1 400 people are affected annually by tumours of the brain in Sweden and twenty per cent of those are afflicted with meningioma. The tumour itself is usually benign, but it can cause severe symptoms owing to of its location and because it is sometimes malignant. It arises from the meninges, and it is more common among women.

The study included samples from a total of 1 633 patients with meningiomas in Sweden, Germany, England, and Denmark. The results were published July 31 in the prestigious journal Nature Genetics.

The gene variant is close to MLLT10 on chromosome 10, a gene known to be involved in hematologic tumours. This gene has not previously been linked to increased risk of tumours.

 - With more research we will be able to examine the function of these variants and whether they correlate with environmental factors, such as ionizing radiation, since the only environmental factor known previously for meningiomas is higher doses of ionizing radiation, says Beatrice Melin.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Developing pre-symptomatic diagnostic tools for Alzheimer's disease using long-read RNA sequencing